Q4 2021 Holdings
Filed 2022-02-14 | 69 holdings | $22.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Coupang Inc(CPNG) | CL A | 22266T109 | $7.5M | 256,264 | 33.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.9M | 5,562 | 8.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.6M | 112,160 | 7.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.6M | 35,232 | 7.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.5M | 52,982 | 6.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.2M | 7,093 | 5.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.2M | 29,856 | 5.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 8,541 | 5.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $1.1M | 13,538 | 4.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $1.0M | 31,493 | 4.4% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $979.0K | 40,549 | 4.3% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $699.0K | 2,580 | 3.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $565.0K | 33,850 | 2.5% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $472.0K | 65,068 | 2.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $185.0K | 20,659 | 0.8% |
| Dell Technologies Inc(DELL) | CL C | 24703L202 | $20.0K | 355,444 | 0.1% |
| Xilinx Inc(XLNXEUR) | COM | 983919101 | $5.1K | 24,173 | 0.0% |
| MSD Acquisition Corp | UNIT 03/25/2026 | G5709C117 | $5.1K | 500,000 | 0.0% |
| IHS Markit LTD(IHS) | SHS | G47567105 | $4.4K | 32,743 | 0.0% |
| Coherent Inc(COHREUR) | COM | 192479103 | $3.6K | 13,600 | 0.0% |
| Nuance Communications Inc | COM | 67020Y100 | $3.6K | 64,841 | 0.0% |
| Peoples United Financial Inc(PBCTEUR) | COM | 712704105 | $3.5K | 196,100 | 0.0% |
| Cyrusone Inc(CONE1EUR) | COM | 23283R100 | $3.5K | 38,700 | 0.0% |
| Change Healthcare Inc(CHNGUSD) | COM | 15912K100 | $3.5K | 162,100 | 0.0% |
| Catalyst Partnrs Acquisitn C | UNIT 99/99/9999 | G19550113 | $2.0K | 200,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $2.0K | 21,433 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.0K | 62,906 | 0.0% |
| Merus N V | COM | N5749R100 | $1.7K | 53,840 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $1.7K | 101,144 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.7K | 54,103 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.6K | 34,487 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.6K | 89,963 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.5K | 13,843 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $1.5K | 113,752 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $1.4K | 45,992 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $1.4K | 28,078 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.4K | 9,236 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.4K | 6,266 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.4K | 23,081 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $1.3K | 113,387 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.3K | 66,639 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $1.2K | 11,298 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.2K | 82,124 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.1K | 5,135 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $1.1K | 577,031 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $1.1K | 23,751 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $1.1K | 17,870 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.1K | 30,999 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.1K | 44,294 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $1.0K | 11,039 | 0.0% |